The ACSO Post: Elacestrant vs Endocrine Monotherapy in Advanced Breast Cancer: Phase III EMERALD Trial

<p>Virginia Kaklamani, MD, Medical Oncology, was quoted in this story.   Read More</p>

Share This Story